Osteogenic BMPs promote tumor growth of human osteosarcomas that harbor differentiation defects.
about
Can heparins stimulate bone cancer stem cells and interfere with tumorigenesis?Carcinoid tumor of the lung with massive ossification: report of a case showing the evidence of osteomimicry and review of the literatureHovenia dulcis Thunb extract and its ingredient methyl vanillate activate Wnt/β-catenin pathway and increase bone mass in growing or ovariectomized micePDGF-induced PI3K-mediated signaling enhances the TGF-β-induced osteogenic differentiation of human mesenchymal stem cells in a TGF-β-activated MEK-dependent mannerMolecular biology and therapeutics in musculoskeletal oncology.Activation of RXR and RAR signaling promotes myogenic differentiation of myoblastic C2C12 cellsElevated tumor and serum levels of the hypoxia-associated protein osteopontin are associated with prognosis for soft tissue sarcoma patients.Expression analysis of genes associated with human osteosarcoma tumors shows correlation of RUNX2 overexpression with poor response to chemotherapy.Manipulation therapy prior to diagnosis induced primary osteosarcoma metastasis--from clinical to basic research.LIM mineralization protein-1 inhibits the malignant phenotypes of human osteosarcoma cells.The piggyBac transposon-mediated expression of SV40 T antigen efficiently immortalizes mouse embryonic fibroblasts (MEFs).Retinoic acids potentiate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells.Therapeutic Implications of PPARgamma in Human Osteosarcoma.Indirect effects of X-irradiation on proliferation and osteogenic potential of bone marrow mesenchymal stem cells in a local irradiated rat modelBone morphogenetic protein-9 effectively induces osteo/odontoblastic differentiation of the reversibly immortalized stem cells of dental apical papillaARTEMIS stabilizes the genome and modulates proliferative responses in multipotent mesenchymal cellsDecellularized liver scaffolds effectively support the proliferation and differentiation of mouse fetal hepatic progenitors.Lysophosphatidic acid acyltransferase β (LPAATβ) promotes the tumor growth of human osteosarcoma.Characterization of retroviral infectivity and superinfection resistance during retrovirus-mediated transduction of mammalian cellsCross-talk between EGF and BMP9 signalling pathways regulates the osteogenic differentiation of mesenchymal stem cellsBone morphogenetic protein 2 inhibits the proliferation and growth of human colorectal cancer cellsThe effect of noncoherent red light irradiation on proliferation and osteogenic differentiation of bone marrow mesenchymal stem cells.Prkar1a is an osteosarcoma tumor suppressor that defines a molecular subclass in miceConditionally immortalized mouse embryonic fibroblasts retain proliferative activity without compromising multipotent differentiation potential.Targeting the osteosarcoma cancer stem cellMultipotential differentiation of human urine-derived stem cells: potential for therapeutic applications in urology.A simplified and versatile system for the simultaneous expression of multiple siRNAs in mammalian cells using Gibson DNA AssemblyTetrandrine inhibits Wnt/β-catenin signaling and suppresses tumor growth of human colorectal cancerCanonical Wnt signaling acts synergistically on BMP9-induced osteo/odontoblastic differentiation of stem cells of dental apical papilla (SCAPs).Defective osteogenic differentiation in the development of osteosarcoma.Endoplasmic reticulum (ER) stress inducible factor cysteine-rich with EGF-like domains 2 (Creld2) is an important mediator of BMP9-regulated osteogenic differentiation of mesenchymal stem cellsCrosstalk between Wnt/β-catenin and estrogen receptor signaling synergistically promotes osteogenic differentiation of mesenchymal progenitor cells.Sustained high level transgene expression in mammalian cells mediated by the optimized piggyBac transposon system.Insulin-like growth factor 2 (IGF-2) potentiates BMP-9-induced osteogenic differentiation and bone formation.BMP-2 inhibits the tumorigenicity of cancer stem cells in human osteosarcoma OS99-1 cell line.A novel function of BMHP1 and cBMHP1 peptides to induce the osteogenic differentiation of mesenchymal stem cells.Characterization of scaffold carriers for BMP9-transduced osteoblastic progenitor cells in bone regeneration.The effect of bone morphogenetic protein-2 on osteosarcoma metastasis.Antibiotic monensin synergizes with EGFR inhibitors and oxaliplatin to suppress the proliferation of human ovarian cancer cells.The Prodomain-Containing BMP9 Produced from a Stable Line Effectively Regulates the Differentiation of Mesenchymal Stem Cells.
P2860
Q26852760-9FF36E23-CD1C-495A-9D0F-4A49A00822F8Q27004294-2ADD2831-444A-4A88-9FEB-7989F213ABC5Q28538976-BEAD2A0E-081E-424C-897A-FA9AD22433C5Q28658995-C57AAB37-8531-4594-B635-900A5AE7CB90Q30426953-C9A1FEED-D318-4EBB-83F9-5C6D3DE76F83Q33475497-F726221E-0A45-4FCF-9410-5548C6EC9041Q33551004-CED3010E-1DB6-4C25-8BF8-6F2AEEE4B446Q33577472-EF4E5C69-DF5E-42DD-91EB-6F6EF51C26A3Q33578156-CADA0760-FE68-4D08-AA3A-B08B6D10D46FQ33580856-48949AD1-67CB-4B40-BD0B-4648AC43FB57Q33638231-E15F7F6B-FF4A-4A96-827A-2DC76CC74B1FQ33651188-43F3CE76-D058-4C16-8F91-BBA43FEDF9ABQ33674615-210452A5-1AD6-467B-981F-7BECB530AD7BQ33702392-1C91E783-27FD-4EB5-91DC-D00AB1ADC8DBQ33713821-22D51C2F-2CAD-4066-9EBF-1F5F359EBA5DQ33729755-C4177320-399E-4324-AFDC-8901FFB550E0Q33751404-73131D0A-059B-44EB-B1CE-9A113283DDBEQ33769959-CD3823A0-AA47-4B2D-941E-640176463D3EQ33895829-ABFCBA85-1324-4C7D-9AA1-68211A14B000Q33985637-15538D70-61C6-4FC3-8C89-68A264899D20Q34000694-D6B1A3A2-B60C-4FEF-B69F-60A8C6E9752EQ34053049-A8EFE43F-44FE-46E5-83BF-F735F928CED9Q34090139-2A8862E6-8BD9-432F-844E-054911563262Q34182685-87DCC751-9D06-4FA2-ABB1-B60731FD306FQ34335524-2C45F30F-53B0-4697-96D2-289AF859BF68Q34344233-6DF8EDC5-3D04-435F-AEAC-4979CA09CE6CQ34514698-BD210D2E-B81E-4F30-A606-792B1F8B205AQ34552005-841F3781-B979-4027-A011-F1AAB9277190Q34644297-2DF757D2-BADE-4809-A80A-D09E6F6000F1Q34700590-AD19C271-15F9-4D3D-84D6-EC8E371D2A4FQ34982792-D50D1E2D-BC17-43BD-8D90-10C430645C1EQ35067794-B0ABE162-EBDC-4420-9E0B-83EA7445D171Q35213346-F3D081FC-E1CC-4F63-9F37-DE9F639A932BQ35229856-24F514B9-C738-4248-B146-D60FCE1B42EAQ35591577-CB5D0542-ADEF-4BB5-B48E-BEE06ACE9249Q35719377-982D7473-DA15-4C63-A129-03FF5861EBADQ35765486-866DCB23-BE50-4339-93BE-25351CAF7E68Q36298450-7147EB76-C25D-49C9-96D5-AA18BC2C8694Q36350112-D190B6E9-0F81-4039-9B87-EB71C328B6B3Q36473791-23D8D0D2-1717-4065-AD91-662851918A39
P2860
Osteogenic BMPs promote tumor growth of human osteosarcomas that harbor differentiation defects.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Osteogenic BMPs promote tumor ...... arbor differentiation defects.
@en
Osteogenic BMPs promote tumor ...... arbor differentiation defects.
@nl
type
label
Osteogenic BMPs promote tumor ...... arbor differentiation defects.
@en
Osteogenic BMPs promote tumor ...... arbor differentiation defects.
@nl
prefLabel
Osteogenic BMPs promote tumor ...... arbor differentiation defects.
@en
Osteogenic BMPs promote tumor ...... arbor differentiation defects.
@nl
P2093
P2860
P1476
Osteogenic BMPs promote tumor ...... arbor differentiation defects.
@en
P2093
Anthony G Montag
Bai-Cheng He
Erwin Bennett
Gao-Hui Zhu
Guo-Wei Zuo
Jeffrey S Souris
Jiayi Huang
P2860
P2888
P304
P356
10.1038/LABINVEST.2008.98
P577
2008-10-06T00:00:00Z